FDA Okays Botox as Treatment for Overactive Bladder

The FDA has approved Botox as an effective treatment for overactive bladder after two clinical trials involving more than 1,100 patients.

During the studies, participants whose bladder muscles were injected with Botox experienced between 1.6 and 1.9 times fewer daily episodes of incontinence compared to those who received the placebo injection. Those who received the Botox injections also had less frequent urges to urinate and produced more urine than the placebo group.

The Botox injections relax the bladder muscle, increasing the bladder's storage capacity.

To learn more, click here.